Business Description
HanchorBio Inc
ISIN : KYG4277B1068
Total Employee Number:
125Description
HanchorBio Inc through its subsidiaries, is conducting research and development of new anti-cancer drugs, utilizing an Fc-based biopharmaceutical platform technology to reactivate the immune system in the fight against disease. The core technology of HanchorBio is the FBDB (Fc-Based Designer Biologics) platform, which focuses on the development of next-generation immuno-oncology fusion protein therapeutics. This platform utilizes the antibody Fc region as a backbone, onto which various engineered anti-cancer molecules are constructed through protein engineering. Combined with AI-assisted drug design capabilities, this technology is dedicated to overcoming key challenges in tumor immunotherapy.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 8.67 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 0.23 | |||||
Debt-to-EBITDA | -0.18 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 28.03 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 496.4 | |||||
3-Year EBITDA Growth Rate | -20.8 | |||||
3-Year EPS without NRI Growth Rate | -5.4 | |||||
3-Year FCF Growth Rate | -22.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 70.66 | |||||
9-Day RSI | 56.1 | |||||
14-Day RSI | 51.62 | |||||
3-1 Month Momentum % | 25.18 | |||||
6-1 Month Momentum % | 37.2 | |||||
12-1 Month Momentum % | 114.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.29 | |||||
Quick Ratio | 2.29 | |||||
Cash Ratio | 2.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.4 | |||||
Shareholder Yield % | -3.49 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -189.66 | |||||
Net Margin % | -146.12 | |||||
EBITDA Margin % | -177.59 | |||||
FCF Margin % | -146.54 | |||||
OCF Margin % | -140.19 | |||||
ROE % | -98.2 | |||||
ROA % | -45.41 | |||||
ROIC % | -300.66 | |||||
3-Year ROIIC % | 492.19 | |||||
ROC (Joel Greenblatt) % | -746.19 | |||||
ROCE % | -84.28 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 61.81 | |||||
PB Ratio | 47.39 | |||||
Price-to-Tangible-Book | 47.71 | |||||
EV-to-EBIT | -35.72 | |||||
EV-to-EBITDA | -38.18 | |||||
EV-to-Revenue | 67.8 | |||||
EV-to-FCF | -46.26 | |||||
| Price-to-Net-Current-Asset-Value | 58.87 | |||||
| Price-to-Net-Cash | 62.4 | |||||
Earnings Yield (Greenblatt) % | -2.8 | |||||
FCF Yield % | -2.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HanchorBio Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 312.223 | ||
| EPS (TTM) (NT$) | -3.584 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 66.07 | ||
| 14-Day RSI | 51.62 | ||
| 14-Day ATR (NT$) | 8.042407 | ||
| 20-Day SMA (NT$) | 153.05 | ||
| 12-1 Month Momentum % | 114.58 | ||
| 52-Week Range (NT$) | 63.7 - 187 | ||
| Shares Outstanding (Mil) | 139.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HanchorBio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HanchorBio Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
HanchorBio Inc Frequently Asked Questions
What is HanchorBio Inc(TPE:7827)'s stock price today?
The current price of TPE:7827 is NT$156.00. The 52 week high of TPE:7827 is NT$187.00 and 52 week low is NT$63.70.
When is next earnings date of HanchorBio Inc(TPE:7827)?
The next earnings date of HanchorBio Inc(TPE:7827) is .
Does HanchorBio Inc(TPE:7827) pay dividends? If so, how much?
HanchorBio Inc(TPE:7827) does not pay dividend.
Press Release
Articles on HanchorBio Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers